Canandaigua National Corp
Source: SEC Form 13F · as of Mar 2026Canandaigua National Corp holds 18 biotech & pharma companies tracked by BioSniper, totaling $67.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$67.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 86,448 | $21.1M |
| MRKMerck & Co., Inc. | 86,888 | $10.5M |
| LLYELI LILLY & Co | 7,956 | $7.3M |
| ABBVAbbVie Inc. | 27,988 | $6.1M |
| ABTABBOTT LABORATORIES | 49,012 | $5.0M |
| PFEPFIZER INC | 159,496 | $4.5M |
| AMGNAMGEN INC | 10,827 | $3.8M |
| MCKMcKesson Corporation | 2,225 | $1.9M |
| BMYBRISTOL MYERS SQUIBB CO | 24,182 | $1.5M |
| PMPhilip Morris International Inc | 6,287 | $1.0M |
| GILDGILEAD SCIENCES, INC. | 5,438 | $758K |
| CAHCardinal Health Inc. | 3,262 | $689K |
| ZTSZoetis Inc. | 5,723 | $677K |
| IDXXIDEXX LABORATORIES INC /DE | 971 | $546K |
| ELVElevance Health Inc. | 1,661 | $486K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,793 | $485K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 827 | $369K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 5,962 | $329K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.